SIMPLifying Elements of Standardized Automated Office Blood Pressure Measurements (Pilot Study) (SIMPLE-AOBP)

This study aims to assess whether removing single elements of the standardized office BP measurement procedure will affect the accuracy towards the mean awake ambulatory BP. Four arms are planned in a randomized order: 1) full standardized procedure, 2) standardized procedure but with cuff placed on a sleeve, 3) standardized procedure but arm resting vertically, 4) standardized procedure but with non-validated device.

This is a pilot study to inform on the sample size required to perform adequately powered large scale studies.

Study Overview

• Status: Completed
• Conditions: Blood Pressure
• Intervention / Treatment: Diagnostic test: Mean awake ambulatory BP measurements

Detailed Description

Accurate and reliable blood pressure (BP) measurements are key for hypertension management. To this regard, all hypertension societies recommend using highly standardized automated oscillometric office BP measurements (AOBP) as a way to minimise measurement biases, enhance reproducibility and allow comparability. The standardized AOBP procedure emphasizes the need to measure BP in a controlled environment with optimal body positioning, the use of an appropriately sized cuff over a bare arm and a clinically validated oscillometric BP devices. It is also recommended to average >2 measurements at 30-60 seconds intervals after several minutes of seated rest alone in a quiet room. As such, important barriers exist to implement standardized AOBP in real-life settings, as this procedure requires time, space and patient mobility.

A 2017 meta-analysis evaluated the impact of several elements of oscillometric and auscultatory BP readings on systolic and diastolic BP levels. It showed that while most components of BP measurements appear to influence BP, the majority of included studies were of relatively low methodological quality (including unstandardized BP measurements, lack of randomisation, auscultatory method, absence or differences in rest periods, single readings, single cuff size) and almost none were compared with th gold-standard BP measurement, i.e average awake ambulatory BP measurements (ABPM). Since, two meta-analyses specifically assessing the effect of attendance during AOBP were published and showed conflicting results. While important components of AOBP (rest period and cuff size) were recently tested using a rigorous methodology, data is still missing for most elements.

Simplifying the AOBP procedure could result in improvements in acceptability and implementation. The need to perform this highly standardized procedure exerts pressure on patients, providers and administrative staff. Indeed, patients need to be properly seated alone in a quiet dedicated room in a chair with an arm rest that need to be adjustable to position the upper arm at heart level. This setup is seldom available apart in highly specialized hypertension clinics. Also, the arm must be bare, which can bring discomfort to patients with the requirement to remove their clothing or roll up the sleeves, which introduces another potential source of inaccuracy due to the tourniquet effect or the inability to completely uncover the upper arm. It can also introduce significant time delays in a clinical setting for less mobile patients. Furthermore, the BP device must be clinically validated for its accuracy. The lack of regulation and the ease of online purchase means many patients may be drawn to purchasing less expensive non-validated devices. While this problem may be more widespread in the home setting, not all office BP measuring devices are validated and recommended by Hypertension Canada.

The primary objective of the SIMPLE-AOBP study is to assess whether foregoing, or simplifying, specific elements of the AOBP procedure affects its accuracy towards the gold-standard mean awake ABPM. This study will employ a rigorous methodology (highly standardized measurements, identical settings and rest periods, randomization, blinded assessment of outcomes, averaged multiple BP measurements) to minimise measurement biases not related to the studies elements. The study will focus on three easily addressable elements: 1) the need the measure BP on a bare arm, 2) the requirement of supporting the arm at heart level and 3) the need to use a validated BP device. This trial will provide important pilot data to help design adequately powered large scale studies.

• Study Type: Interventional
• Enrollment (Actual): 30
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Canada
  • Quebec
    • Montréal, Quebec, Canada, H4J1C5
      • Hopital du Sacre-Coeur de Montreal

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Adults ≥ 18 years old

Exclusion Criteria:

• Upper arm size outside of cuff range of selected devices (<22 cm or >42 cm)
• Permanent atrial fibrillation
• Known severe aortic stenosis
• Ongoing pregnancy
• Inability or unwillingness to provide consent

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Diagnostic
• Allocation: Randomized
• Interventional Model: Crossover Assignment
• Masking: Single

Number of Arms

4

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Standardized automated office BP measurements; BP measured using a highly standardized procedure using a validated office-grade device on a bare arm supported at heart level.	Diagnostic test: Mean awake ambulatory BP measurements; Results from all four arms will be compared to the mean awake ambulatory BP measured on the same arm and started immediately following completion of the testing protocol.
Active Comparator: Sleeved arm; BP measured using a highly standardized procedure using a validated office-grade device over a standardized sleeve with the arm supported at heart level.	Diagnostic test: Mean awake ambulatory BP measurements; Results from all four arms will be compared to the mean awake ambulatory BP measured on the same arm and started immediately following completion of the testing protocol.
Active Comparator: Arm not supported; BP measured using a highly standardized procedure using a validated office-grade device on a bare arm resting vertically.	Diagnostic test: Mean awake ambulatory BP measurements; Results from all four arms will be compared to the mean awake ambulatory BP measured on the same arm and started immediately following completion of the testing protocol.
Active Comparator: Non-validated device; BP measured using a highly standardized procedure using a non-validated home device on a bare arm supported at heart level.	Diagnostic test: Mean awake ambulatory BP measurements; Results from all four arms will be compared to the mean awake ambulatory BP measured on the same arm and started immediately following completion of the testing protocol.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Difference with mean awake ambulatory systolic BP	Difference between systolic BP measured in each study arm (average of 3 measurements) with the mean awake ambulatory systolic BP	at enrollment (time 0)

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Difference with mean awake ambulatory diastolic BP	Difference between diastolic BP measured in each study arm (average of 3 measurements) with the mean awake ambulatory diastolic BP	at enrollment (time 0)

Collaborators and Investigators

• Sponsor: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal

Study record dates

Study Major Dates

• Study Start (Actual): May 9, 2024
• Primary Completion (Actual): September 5, 2024
• Study Completion (Actual): September 5, 2024

Study Registration Dates

• First Submitted: March 11, 2024
• First Submitted That Met QC Criteria: March 15, 2024
• First Posted (Actual): March 19, 2024

Study Record Updates

• Last Update Posted (Actual): March 25, 2025
• Last Update Submitted That Met QC Criteria: February 10, 2025
• Last Verified: February 1, 2025

More Information

Terms related to this study

• Keywords: blood pressure measurements
• Other Study ID Numbers: SIMPLE-AOBP

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO
• IPD Plan Description: Data will not be shared (pilot study)

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No